Scientific Program
|
Time |
Virtually from Ulaanbaatar, Mongolia |
Title |
|
|
09:00-09:05 |
President of ICOT-2021 Sergelen Orgoi |
Open speech |
|
|
09:05-09:10 |
Minister of Health Enkhbold Sereejav |
||
|
09:10-09:15 |
Raphael International Curie Ahn |
||
|
09:15-09:20 |
Director of FCHM Khishigjargal Batsukh |
||
|
09:20-09:25 |
President of MOTA Nyamsuren Davaajav |
||
|
Invited speakers |
|||
|
09:25-09:45 |
Maurice Slapak |
CBE,OBS(Ken), FM(Mong) M.Chir, FRCS(Eng). FRCS(Can),FACS |
Fact or Fiction. The Effect of: COVID 19 on Organ Transplantation—the Good, the Bad and Indifferent. |
|
09:45-10:05 |
Manuel Rodriguez Davalos |
Sur.Director Pediatric Liver Transplantation, Medical Director Living Liver Donor Program /Intermountain Medical Center/ |
Segmental Grafts for Pediatric Liver Transplantation |
|
10:05-10:25 |
Duck Jong Han |
Honorary Professor, Asan Medical Center |
Current state of pancreas and kidney-pancreas transplantation |
|
10:25-10:40 |
Discussions |
||
|
10:40-11:00 |
Coffee break |
||
|
Liver Transplantation Session:
|
|||
|
11:00-11:10 |
Batsaikhan Batsuuri |
Transplant surgeon, COT, FCHM |
Study of recipient site effects leading to renal impairment after liver transplant surgery |
|
11:10-11:20 |
Bat-Ireedui Badarch |
Transplant surgeon, COT, FCHM |
Study of Living Donors For LT |
|
11:20-11:30 |
Tamir Sainbuyan |
Surgeon, MNUMS |
Determining the optimal dose of immunosuppressant drug after liver transplantation |
|
11:30-11:40 |
Urnultsaikhan Ganbold |
Radiologist, DR, FCHM |
Interventional radiological procedures post living donor liver transplantation |
|
11:40-11:50 |
Anar Ganbold |
Gastroenterologist, DG, FCHM |
Incidences of Acute Hepatitis over a 30 year period and actions taken to mitigate it |
|
11:50-12:00 |
Tsendjav A. |
Surgeon, NCMCH |
Evaluation of Life Quality and Survival Rate in Children Who had Liver Transplantation |
|
12:00-12:20 |
Discussions |
||
|
Kidney Transplantation Session:
|
|||
|
12:20-12:30 |
Banzragch Oyunbileg |
Immunology, LD, FCHM |
Anti-SARS-Cov2 Antibody Response After mRNA Vaccination in Kidney Transplant Recipients |
|
12:30-12:40 |
Ariunbold Jamba |
Nephrology, OD, FCHM |
COVID-19 incidence in Kidney Transplantation Recipient |
|
12:40-12:50 |
Od-Erdene Lkhakhuu |
Nephrology, COT, FCHM |
Gender imbalance, it’s influence in Kidney Transplantation |
|
12:50-13:00 |
Saruultuvshin Adiya |
Nephrology, KC, FCHM |
Long-term Kidney Transplant Survival |
|
13:00-13:20 |
Discussions |
||
|
13:20-13:40 |
Lunch |
||
|
Deceased Donor and Bone Marrow Transplantation:
|
|||
|
13:40-13:50 |
Enkhtaivan Narangerel |
Orthopedic surgeon, FCHM |
Early Outcome of Autograft Versus Allograft in Anterior Cruciate Ligament Reconstruction |
|
13:50-14:00 |
Altantulga Bayaraa |
Physician, CHD |
Family Consent and Allocation |
|
14:10-14:20 |
Baljinnyam P. |
Physician, Center of Hematology, Blood and Marrow Transplantation, FCHM |
The Result of Autologous Stem Cell Transplantation in Mongolia |
|
14:20-14:30 |
Myagmarsuren U. |
Nurse, COT, FCHM |
Evaluating the Health Education of Transplant Recipients |
|
14:40-14:50 |
Unursaikhan Chadraabal |
Surgeon, Ph.D, TCHM |
Medical Care Management for Brain Death Donors occurred in Mongolia |
| 14:50-15:00 | Sumiya Bayarsaikhan | Gastroenterologist, DG, FCH | Some indicators of mRNA-based COVID-19 vaccine safety in liver transplant recipients |
|
15:00-15:20 |
Discussions |
||
|
15:20-15:30 |
President of ICOT-2021 O.Sergelen |
Closing speech |
|